{"database": "lobbying", "table": "lobbying_activities", "rows": [[2682554, "a3df2660-d18e-4b67-86cf-7312571df5c8", "Q3", "MARSHALL & POPP, LLC", 401105121, "AMGEN USA INC.", 2021, "third_quarter", "CPT", "Issues related to intellectual property and patent reform, including S.1435, the Affordable Prescriptions for Patients Act and S.1260, the United States Innovation and Competition Act.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2021-10-16T08:51:29.393000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2682554"], "units": {}, "query_ms": 167.53153002355248, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}